88094-35-3Relevant academic research and scientific papers
Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers
Purohit, Ajay,Radeke, Heike,Azure, Michael,Hanson, Kelley,Benetti, Richard,Su, Fran,Yalamanchili, Padmaja,Yu, Ming,Hayes, Megan,Guaraldi, Mary,Kagan, Mikhail,Robinson, Simon,Casebier, David
experimental part, p. 2954 - 2970 (2009/05/27)
A series of fluorinated pyridazinone derivatives with IC50 values ranging from 8 to 4000 nM for the mitochondrial complex 1 (MC1) have been prepared. Structure-activity relationship (SAR) assessment indicated preference of the fluorine label to be incorporated on an alkyl side chain rather than directly on the pyridazinone moiety. Tissue distribution studies of a series of analogues ([18F] 22-28) in Sprague-Dawley (SD) rats identified [ 18F]27 as the most promising radiotracer with high uptake in cardiac tissue (3.41%ID/g; 30 min post injection) in addition to favorable heart to nontarget organ distribution ratios. MicroPET images of SD rats and nonhuman primates after [18F]27 administration allowed easy assessment of the myocardium through 60 min with minimal lung or liver interference.
Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation
-
, (2008/06/13)
Anti-tomor agents comprising novel 3(2H)-pyridazinone derivatives or salts thereof and methods of producing the same are disclosed. Also disclosed is a method for treating or preventing tumors by administering to a mammal a therapeutically effective amount of 4,5-di substituted 3(2H)-pyridazinones and salts thereof.
